| Development and external validation of a nomogram for overall survival after curative resection in serosa-negative, locally advanced gastric cancer S Hirabayashi, S Kosugi, Y Isobe, A Nashimoto, I Oda, K Hayashi, ... Annals of oncology 25 (6), 1179-1184, 2014 | 109 | 2014 |
| NET-CAGE characterizes the dynamics and topology of human transcribed cis-regulatory elements S Hirabayashi, S Bhagat, YU Matsuki, Y Takegami, T Uehata, ... Nature genetics 51 (9), 1369-1379, 2019 | 92 | 2019 |
| Gastric cancer treated by endoscopic submucosal dissection or endoscopic mucosal resection in Japan from 2004 through 2006: JGCA nationwide registry conducted in 2013 S Tanabe, S Hirabayashi, I Oda, H Ono, A Nashimoto, Y Isobe, I Miyashiro, ... Gastric Cancer 20, 834-842, 2017 | 64 | 2017 |
| Endogenous APOBEC3B overexpression constitutively generates DNA substitutions and deletions in myeloma cells H Yamazaki, K Shirakawa, T Matsumoto, S Hirabayashi, Y Murakawa, ... Scientific reports 9 (1), 7122, 2019 | 35 | 2019 |
| Differential effect of graft-versus-host disease on survival in acute leukemia according to donor type T Konuma, J Kanda, Y Kuwatsuka, M Yanada, T Kondo, S Hirabayashi, ... Clinical Cancer Research 27 (17), 4825-4835, 2021 | 25 | 2021 |
| Comparing cord blood transplantation and matched related donor transplantation in non-remission acute myeloid leukemia Y Shimomura, T Sobue, S Hirabayashi, T Kondo, S Mizuno, J Kanda, ... Leukemia 36 (4), 1132-1138, 2022 | 22 | 2022 |
| APOBEC3B is preferentially expressed at the G2/M phase of cell cycle S Hirabayashi, K Shirakawa, Y Horisawa, T Matsumoto, H Matsui, ... Biochemical and biophysical research communications 546, 178-184, 2021 | 17 | 2021 |
| Targeting a mitochondrial E3 ubiquitin ligase complex to overcome AML cell-intrinsic Venetoclax resistance F Nakao, K Setoguchi, Y Semba, T Yamauchi, J Nogami, K Sasaki, ... Leukemia 37 (5), 1028-1038, 2023 | 15 | 2023 |
| HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia Y Takiuchi, M Kobayashi, K Tada, F Iwai, M Sakurada, S Hirabayashi, ... Scientific reports 7 (1), 12849, 2017 | 15 | 2017 |
| Identification of candidate PAX2-regulated genes implicated in human kidney development Y Yamamura, K Furuichi, Y Murakawa, S Hirabayashi, M Yoshihara, ... Scientific reports 11 (1), 9123, 2021 | 14 | 2021 |
| Advantages of peripheral blood stem cells from unrelated donors versus bone marrow transplants in outcomes of adult acute myeloid leukemia patients T Jo, Y Arai, T Kondo, S Mizuno, S Hirabayashi, Y Inamoto, N Doki, ... Cytotherapy 24 (10), 1013-1025, 2022 | 13 | 2022 |
| Measurable residual disease affects allogeneic hematopoietic cell transplantation in Ph+ ALL during both CR1 and CR2 S Nishiwaki, Y Akahoshi, S Mizuta, A Shinohara, S Hirabayashi, ... Blood advances 5 (2), 584-592, 2021 | 13 | 2021 |
| Comparison of fludarabine, a myeloablative dose of busulfan, and melphalan vs conventional myeloablative conditioning regimen in patients with relapse and refractory acute … Y Shimomura, M Hara, S Hirabayashi, T Kondo, S Mizuno, N Uchida, ... Bone Marrow Transplantation 56 (9), 2302-2304, 2021 | 10 | 2021 |
| Effect of multiple HLA locus mismatches on outcomes after single cord blood transplantation J Kanda, S Hirabayashi, H Yokoyama, T Kawase, H Tanaka, N Uchida, ... Transplantation and Cellular Therapy 28 (7), 398. e1-398. e9, 2022 | 9 | 2022 |
| The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic … T Tachibana, Y Najima, Y Akahoshi, S Hirabayashi, K Harada, N Doki, ... Annals of Hematology 99, 2393-2404, 2020 | 7 | 2020 |
| Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy‐refractory or relapsed disease prior to allogeneic stem cell … M Nakamura, Y Arai, S Hirabayashi, T Kondo, N Doki, N Uchida, ... British journal of haematology 194 (2), 403-413, 2021 | 5 | 2021 |
| The differential effect of disease status at allogeneic hematopoietic cell transplantation on outcomes in acute myeloid and lymphoblastic leukemia M Yanada, T Konuma, S Yamasaki, S Mizuno, S Hirabayashi, S Nishiwaki, ... Annals of Hematology 100, 3017-3027, 2021 | 4 | 2021 |
| An atlas of transcribed enhancers across helper T cell diversity for decoding human diseases A Oguchi, A Suzuki, S Komatsu, H Yoshitomi, S Bhagat, R Son, ... Science 385 (6704), eadd8394, 2024 | 3 | 2024 |
| Clear paint composition and clear coat film using same H Yokoyama, M Yamanaka, K Watanabe, T Higuchi, S Hirabayashi US Patent App. 11/269,708, 2006 | 3 | 2006 |
| Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph+ ALL: A retrospective nationwide study S Hirabayashi, T Kondo, S Nishiwaki, S Mizuta, N Doki, T Fukuda, ... American Journal of Hematology 98 (10), 1606-1618, 2023 | 2 | 2023 |
